Corvex Management’s Allergan plc AGN Stock Holding History

Corvex Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-107,221	Closed	-$24.7M	–	39
2016 Q1	$28.7M	Sell	107,221 -611,839	-85%	-$175M	0.47%	18
2015 Q4	$225M	Sell	719,060 -1,289,933	-64%	-$384M	2.99%	8
2015 Q3	$546M	Buy	2,008,993 +464,090	+30%	+$143M	6.42%	6
2015 Q2	$469M	Buy	1,544,903 +205,000	+15%	+$61.1M	5.13%	6
2015 Q1	$399M	Buy	1,339,903 +68,100	+5%	+$19.4M	4.82%	6
2014 Q4	$327M	Sell	1,271,803 -125,000	-9%	-$31.2M	4.02%	7
2014 Q3	$337M	Buy	1,396,803 +218,990	+19%	+$49M	4.07%	7
2014 Q2	$263M	Buy	1,177,813 +441,200	+60%	+$91.4M	3.12%	9
2014 Q1	$152M	Buy	736,613 +536,857	+269%	+$106M	2.13%	13
2013 Q4	$33.6M	Buy	+199,756	New	+$31.2M	0.69%	32

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Corvex Management's AGN Position: Q2 2016 in Review

Corvex Management sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 107,221 shares — an estimated $24.7M sold.

Corvex Management first reported a position in AGN in Q4 2013 and held it in 10 quarters. The position peaked at $546M in Q3 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Corvex Management reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
Corvex Management sold 107,221 Allergan plc shares in Q2 2016, an estimated $24.7M.
Corvex Management first reported a position in Allergan plc in Q4 2013 and held it in 10 quarters.
Corvex Management's Allergan plc position peaked at $546M in Q3 2015.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Corvex Management's 13F filing for Q2 2016, filed 15 Aug 2016.